Corbus Pharmaceuticals Holdings, Inc. Deferred Tax Assets, Operating Loss Carryforwards, State and Local
Corbus Pharmaceuticals Holdings, Inc. (CRBP) had Deferred Tax Assets, Operating Loss Carryforwards, State and Local of $1.43 million as of 2017-12-31, per its 10-K filed 2019-03-12.
Discontinued › Notes › Income Taxes
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal · last filed 2019-03-12
- 2017-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $1.43M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, State and Local |
|---|---|
| 2017-12-31 | $1.43M 10-K · filed 2019-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |